Trial · NCT06066827
Hair Regeneration in Androgenetic Alopecia
NCT06066827, Not applicable, Unknown, Dr. dr. Lili Legiawati, SpKK(K)
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Hair Regeneration in Androgenetic Alopecia. Trials, record NCT06066827. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06066827
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Hair Regeneration in Androgenetic Alopecia
- NCT number
- NCT06066827
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 60 participants, actual
- Lead sponsor
- Dr. dr. Lili Legiawati, SpKK(K)
- Conditions
- Androgenetic Alopecia
- Interventions
- Minoxidil Topical, Secretome from adipose-derived stem cells, Combination of minoxidil and secretome from adipose-derived stem cells
- First posted
- 2023-10-04
- Last updated
- 2023-10-10
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Improvement of alopecia in physical examination | Week 0 (baseline), week 4 after intervention, week 8 after intervention, week 12 (end of trial) | The investigator conduct a scalp examination every 4 weeks until the twelfth week to measure the improvement of alopecia with Hamilton-Norwood scale |
| Primary | Macroscopic hair growth documented | Week 0 (baseline), week 4 after intervention, week 8 after intervention, week 12 (end of trial) | The investigator conducted documentation of the subject in 7 positions, so that the improvement of alopecia can be seen from various directions |
| Primary | Microscopic hair growth evaluated by Trichoscopy | Week 0 (baseline), week 4 after intervention, week 8 after intervention, week 12 (end of trial) | Microscopic hair growth was documented using Heine® Delta 20 Plus (Heine, Germany) dermoscopy for qualitative measurement |
| Primary | Microscopic hair growth evaluated by Trichoscan | Week 0 (baseline), week 4 after intervention, week 8 after intervention, week 12 (end of trial) | The investigator use Fotofinder® medicam 1000 s video-trichoscopy (FotoFinder Systems GmbH, Germany) for quantitative measurements, such as hair rate anagen (%), hair rate telogen (%), hair rate terminal (%), and hair rate vellus (%) |
| Secondary | Patient satisfaction | Week 12 (end of trial) | The patient satisfaction scale using a linear analog scale with a scale of 1-7 (1 = no result, 7 = very satisfactory outcome) and was evaluated at the last treatment session. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 40021536 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06066827
GET https://conductscience.org/api/trials/v1/NCT06066827/registered